Skip to content

Clinical characteristics of IgG4-related cholecystitis

Clinical characteristics of IgG4-related cholecystitis - Clinical characteristics of IgG4-related cholecystitis

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
JPRN
Registry ID
JPRN-UMIN000052983
Enrollment
25
Registered
2023-12-03
Start date
2023-09-26
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

IgG4-related cholecystitis

Interventions

None listed

Sponsors

Nagoya City University Midori Municipal Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. IgG4-related cholecystitis confirmed histopathologically 2. IgG4-related cholecystitis immproved by steroid therapy

Exclusion criteria

Exclusion criteria: Patients who reject to participate this study

Design outcomes

Primary

MeasureTime frame
Clinical, imaging and histopathological characteristics of IgG4-related cholecystitis

Countries

Japan

Contacts

Public ContactItaru Naitoh

Nagoya City University Midori Municipal Hospital Department of Gastroenterology

inaito@med.nagoya-cu.ac.jp052-892-1331

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026